3.0
Mar 29, 2013
Anonymous employee
Current employee, more than 3 years
Recommend
CEO approval
Business Outlook
Pros
Globally positioned even higher now that it is a division of Novartis
Cons
Definitely changing -- reduction in staff and culturally business only is where it is headed...